Kay Hofmann
3Patents
2h-index
5Co-inventors
33Inventor score
Filing activity: Aug 10, 2005 → Feb 14, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8283319B2 | Therapeutic application of Kazal-type serine protease inhibitors | Human Necessities | 30 | Active |
| US9458223B2 | Von willebrand factor variants having improved factor VIII binding affinity | Human Necessities | 2 | Active |
| US8828939B2 | Modified vitamin K dependent polypeptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.